title: Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma.
abstract: Carcinomatous encephalitis is a rapidly fatal form of metastasis caused by miliary spread of systemic cancer into the brain parenchyma. The diagnostic criteria and optimal treatment for this disease are not well defined. We report a patient with rapid neurologic deterioration from carcinomatous encephalitis from lung adenocarcinoma. She was treated with gefitinib and high-dose fractionated whole brain radiotherapy, and eventually improved neurologically and was discharged home on hospital day 48. Gefitinib and high-dose fractionated radiotherapy may have synergistic activity in patients with carcinomatous encephalitis from non-small cell lung cancer having favorable prognostic factors. More importantly, timely recognition of this disease and the use of large fraction radiation therapy are necessary to control rapid neurologic deterioration.
authors.affiliation: Department of Neurology.
authors.forename: Eric T
authors.initials: ET
authors.lastname: Wong
authors.forename: Julian K
authors.initials: JK
authors.lastname: Wu
authors.forename: Anand
authors.initials: A
authors.lastname: Mahadevan
references.citation: J Clin Oncol. 2005 Apr 10;23(11):2493-501
references.pmid: 15710947
references.citation: JAMA. 2003 Oct 22;290(16):2149-58
references.pmid: 14570950
references.citation: J Clin Oncol. 2006 Sep 20;24(27):4517-20
references.pmid: 16983123
references.citation: Int J Radiat Oncol Biol Phys. 1981 Dec;7(12):1633-8
references.pmid: 6174490
references.citation: Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8
references.pmid: 12516034
references.citation: Science. 2004 Aug 20;305(5687):1163-7
references.pmid: 15284455
references.citation: J Clin Oncol. 2005 Apr 10;23(11):2513-20
references.pmid: 15738541
references.citation: J Clin Oncol. 2004 Mar 15;22(6):1103-9
references.pmid: 15020612
references.citation: Br J Cancer. 2004 Dec 13;91(12):2026-33
references.pmid: 15545965
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: AJNR Am J Neuroradiol. 1993 May-Jun;14(3):540-2
references.pmid: 8517338
references.citation: Neuroradiology. 1997 Jun;39(6):437-40
references.pmid: 9225326
references.citation: Clin Cancer Res. 2002 Oct;8(10):3250-8
references.pmid: 12374696
references.citation: AMA Arch Neurol Psychiatry. 1951 Feb;65(2):161-73
references.pmid: 14798993
references.citation: Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9
references.pmid: 6154024
references.citation: Br J Cancer. 2003 Dec;89 Suppl 2:S15-8
references.pmid: 14661048
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2237-46
references.pmid: 12748244
references.citation: Neurology. 2005 Jul 12;65(1):165
references.pmid: 16009912